Why the study?
Are microalbuminuria, hs-CRP, and LDL levels elevated in nondiabetic, nonhypertensive myocardial infarction patients compared to healthy controls?
Are microalbuminuria, hs-CRP, and LDL levels elevated in nondiabetic, nonhypertensive myocardial infarction patients compared to healthy controls?
Microalbuminuria and hs-CRP are significantly elevated in nondiabetic, nonhypertensive MI patients, suggesting their potential utility in cardiovascular risk prediction alongside traditional lipid profiles.
Answers are grounded in this paper and cite their sources.
Associations in nondiabetic MI patients should not change practice; leaves open incremental predictive value of microalbumin and hs-CRP.
INTRODUCTION: Microalbuminuria (MA), defined as urine albumin to urine creatinine ratio (UACR) of 30 to 300 mg/G of creatinine, is an established risk factor for cardiovascular morbidity and mortality and for end-stage renal disease in individuals with an adverse cardiovascular risk profile such as those with hypertension or/and diabetes mellitus. MATERIALS AND METHODS: Thirty five patients were included in the study and equal number of age- and sex-matched controls were also included. 2 ml of venous blood was collected for hs-CRP determination and early morning mid stream urine sample was collected under strict aseptic precautions. The lipid profile was estimated in cobas autoanalyzer. RESULTS: There was significant increase in levels of Low density lipoprotein (LDL) cholesterol, microalbumin, and hs-CRP (P< 0.001) in patients with myocardial infarction compared to healthy controls. CONCLUSION: Therefore, MA and hsCRP evaluation may have potential role in improving cardiovascular risk prediction, when used along with traditional lipid profiles.
No takes yet. Share an insight, caveat, or question.
Goud et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: